§ Research summary · Dermal

Melanotan II 10 mg

Also known as · MT-2 · Melanotan 2 · MT2

Dermal·1 min read·reviewed 2026-05-07

Melanotan II is a synthetic cyclic heptapeptide non-selective melanocortin-receptor agonist (MC1R / MC3R / MC4R / MC5R).

Chemistry quick-facts

CAS
121062-08-6
Formula
C50H69N15O9
MW
1024.18 Da
Length
7 aa
Status
Investigational. Early Phase 1 trials for photoprotection in the 1990s; no regulatory approval for any indication.
Purity (HPLC)
≥ 99.0%

Mechanism of action

Non-selective agonism at melanocortin receptors MC1R, MC3R, MC4R, MC5R. MC1R activation modulates melanogenesis in melanocytes.

Research context

Melanotan II was originally developed at the University of Arizona as a more potent, longer-acting analogue of α-MSH. The cyclic structure confers metabolic stability not present in native α-MSH.

Historical Phase 1 trials evaluated MT-II for photoprotection research. No progression to approved therapeutic use. MT-1 (afamelanotide) is the related linear analogue that reached approval for erythropoietic protoporphyria in specific jurisdictions.

Published studies

A non-exhaustive list of peer-reviewed studies referenced when curating this entry. Click through to the primary source for the full text.

  1. Dorr RT, Lines R, Levine N, et al. (1996). Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide. Life Sciences.

Reconstitution

Solvent
Bacteriostatic water for injection (0.9% benzyl alcohol) — included with kit
Typical volume
1 – 2 mL
  • · Inject diluent slowly down the side of the vial onto the cake.
  • · Swirl gently — do not shake.
  • · Solution should be clear and colourless. Discard if not.

Storage

Lyophilised
−20 °C, desiccated, protected from light. Stable at 15–25 °C for up to 30 days in transit.
Reconstituted
2–8 °C, original vial, consumed within 4 weeks.
Shelf life — sealed
24 months from date of manufacture when stored lyophilised at −20 °C.

FAQ

How does this differ from MT-1 (afamelanotide)?+

MT-1 is a linear α-MSH analogue with MC1R selectivity and has reached approval for a narrow therapeutic indication (erythropoietic protoporphyria). MT-II is a cyclic non-selective melanocortin agonist — research use only.

Research-use disclaimer

This page summarises the research literature on Melanotan II 10 mg for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.

View Melanotan II 10 mg in the catalogue →
§ Related reading